BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6413884)

  • 1. Effect of mannitol on increased intracranial pressure.
    McGraw CP; Howard G
    Neurosurgery; 1983 Sep; 13(3):269-71. PubMed ID: 6413884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furosemide and mannitol in the treatment of acute experimental intracranial hypertension.
    Wilkinson HA; Rosenfeld SR
    Neurosurgery; 1983 Apr; 12(4):405-10. PubMed ID: 6406929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical study of mannitol and glycerol on raised intracranial pressure and on their rebound phenomenon.
    Node Y; Nakazawa S
    Adv Neurol; 1990; 52():359-63. PubMed ID: 2118716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetic basis of mannitol administration in the treatment of raised ICP].
    Tanaka M; Yoshiyama Y; Kobayashi T; Tomonaga F; Kondo R; Takagi H; Ohwada T
    No Shinkei Geka; 1991 Jul; 19(7):619-24. PubMed ID: 1909772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dose and dose schedule on the response of intracranial pressure to mannitol.
    McGraw CP; Alexander E; Howard G
    Surg Neurol; 1978 Aug; 10(2):127-30. PubMed ID: 705588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mannitol dose requirements in brain-injured patients.
    Marshall LF; SMith RW; Rauscher LA; Shapiro HM
    J Neurosurg; 1978 Feb; 48(2):169-72. PubMed ID: 624964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury.
    Mangat HS; Chiu YL; Gerber LM; Alimi M; Ghajar J; Härtl R
    J Neurosurg; 2015 Jan; 122(1):202-10. PubMed ID: 25380107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the dose-response relationship between mannitol and intracranial pressure in traumatic brain injury patients using a high-frequency physiological data collection system.
    Sorani MD; Morabito D; Rosenthal G; Giacomini KM; Manley GT
    J Neurotrauma; 2008 Apr; 25(4):291-8. PubMed ID: 18373479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracranial pressure response after pharmacologic treatment of intracranial hypertension.
    Colton K; Yang S; Hu PF; Chen HH; Bonds B; Scalea TM; Stein DM
    J Trauma Acute Care Surg; 2014 Jul; 77(1):47-53; discussion 53. PubMed ID: 24977754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of indomethacin in brain-injured patients with cerebral perfusion pressure impairment: preliminary report.
    Biestro AA; Alberti RA; Soca AE; Cancela M; Puppo CB; Borovich B
    J Neurosurg; 1995 Oct; 83(4):627-30. PubMed ID: 7674011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients.
    Muizelaar JP; Lutz HA; Becker DP
    J Neurosurg; 1984 Oct; 61(4):700-6. PubMed ID: 6432972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The University of Toronto head injury treatment study: a prospective, randomized comparison of pentobarbital and mannitol.
    Schwartz ML; Tator CH; Rowed DW; Reid SR; Meguro K; Andrews DF
    Can J Neurol Sci; 1984 Nov; 11(4):434-40. PubMed ID: 6440704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic Treatment Reduces Pressure Times Time Dose and Relative Duration of Intracranial Hypertension.
    Colton K; Yang S; Hu PF; Chen HH; Bonds B; Stansbury LG; Scalea TM; Stein DM
    J Intensive Care Med; 2016 May; 31(4):263-9. PubMed ID: 25320157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of mannitol on intracranial pressure in relation to serum osmolality in a cat model of cerebral edema.
    Silver P; Nimkoff L; Siddiqi Z; Estrada R; Sagy M
    Intensive Care Med; 1996 May; 22(5):434-8. PubMed ID: 8796395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study.
    Kerwin AJ; Schinco MA; Tepas JJ; Renfro WH; Vitarbo EA; Muehlberger M
    J Trauma; 2009 Aug; 67(2):277-82. PubMed ID: 19667879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mannitol bolus administration on intracranial pressure, cerebral extracellular metabolites, and tissue oxygenation in severely head-injured patients.
    Sakowitz OW; Stover JF; Sarrafzadeh AS; Unterberg AW; Kiening KL
    J Trauma; 2007 Feb; 62(2):292-8. PubMed ID: 17297315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect on intracranial pressure of furosemide combined with varying doses and administration rates of mannitol.
    Roberts PA; Pollay M; Engles C; Pendleton B; Reynolds E; Stevens FA
    J Neurosurg; 1987 Mar; 66(3):440-6. PubMed ID: 3102698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-assisted analysis of intraventricular pressure after mannitol administration.
    Szewczykowski J; Sliwka S; Kunicki A; Korsak-Sliwka J; Dziduszko J; Dytko P; Augustyniak B
    J Neurosurg; 1975 Aug; 43(2):136-41. PubMed ID: 1185246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of mannitol in severe head injury. Brain Trauma Foundation.
    J Neurotrauma; 1996 Nov; 13(11):705-9. PubMed ID: 8941889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral perfusion pressure: a hemodynamic mechanism of mannitol and the postmannitol hemogram.
    Rosner MJ; Coley I
    Neurosurgery; 1987 Aug; 21(2):147-56. PubMed ID: 3116451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.